GECH
MED icon

Garnet Equity Capital Holdings’s Medifast MED Stock Holding History

Garnet Equity Capital Holdings’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-8,000
Closed -$829K – 24
2019
Q3 		$829K Buy
+8,000
New +$860K 0.53% 19

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Garnet Equity Capital Holdings's MED Position: Q4 2019 in Review

Garnet Equity Capital Holdings sold out of Medifast (MED) in Q4 2019, closing a stake of 8,000 shares — an estimated $829K sold.

Garnet Equity Capital Holdings first reported a position in MED in Q3 2019 and held it in 1 quarter. The position peaked at $829K in Q3 2019. 219 funds tracked by Wall St. Rank hold MED as of Q4 2019.

  • Garnet Equity Capital Holdings reported no remaining Medifast position as of Q4 2019 after selling out during the quarter.
  • Garnet Equity Capital Holdings sold 8,000 Medifast shares in Q4 2019, an estimated $829K.
  • Garnet Equity Capital Holdings first reported a position in Medifast in Q3 2019 and held it in 1 quarter.
  • Garnet Equity Capital Holdings's Medifast position peaked at $829K in Q3 2019.
  • 219 funds tracked by Wall St. Rank held Medifast as of Q4 2019.

Based on Garnet Equity Capital Holdings's 13F filing for Q4 2019, filed 14 Jan 2020.